logo
Select company
Select metric
-7838.62%EBIT Margin
VS
Market
2
Sector
7
Industry
5
History
-
$ 4.49Close
$ 1.71 - $ 12.7 52-Week Range
Ticker Information

Ticker

CATX

Company Name

PERSPECTIVE THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NYSEMKT

PERSPECTIVE THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CATX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -96.81M-7838.62%$ 1.24M
3/31/2025$ -87.12M-5922.64%$ 1.47M
12/31/2024$ -81.33M-5593.4%$ 1.45M
9/30/2024$ -55.79M0%$ -3.68M
6/30/2024$ -51.08M0%$ -1.87M
3/31/2024$ -50.48M0%$ -304K
12/31/2023$ -49.08M-3422.25%$ 1.43M
9/30/2023$ -35.54M-434.95%$ 8.17M
6/30/2023$ -29.27M-379.93%$ 7.7M
3/31/2023$ -20.27M-249.58%$ 8.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PERSPECTIVE THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -34.29%.
  • Over the past 5 years, PERSPECTIVE THERAPEUTICS INC's average EBIT % has been -1436.23%.
  • The median EBIT % for PERSPECTIVE THERAPEUTICS INC during this period was -91.45%
  • PERSPECTIVE THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -33.47%.
  • The lowest EBIT % recorded by PERSPECTIVE THERAPEUTICS INC in the same timeframe -7838.62%

PERSPECTIVE THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
RNAC : CARTESIAN THERAPEUTICS INC -3506.14%INBX : INHIBRX BIOSCIENCES INC -11275.86%NWBO : NORTHWEST BIOTHERAPEUTICS INC -6793.6%HUMA : HUMACYTE INC -5888.75%SI : SHOULDER INNOVATIONS INC -PAVM : PAVMED INC 7147.45%CODX : CO-DIAGNOSTICS INC -3582.18%MGRM : MONOGRAM TECHNOLOGIES INC -MREO : MEREO BIOPHARMA GROUP PLC -10070%CV : CAPSOVISION INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for PERSPECTIVE THERAPEUTICS INC is calculated as follows: EBIT [ $ -3.34M ] / Revenues [ $ 9.75M ]
(=) EBIT % [ -34.29% ]

CATX - EBIT Margin, Last 5 years

-7838.62%

Minimum

Jun 30, 2025

-33.47%

Maximum

Dec 31, 2020

-1436.23%

Average

-91.45%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%